Zevra Therapeutics, Inc. (ZVRA)
9.49
+0.36
(+3.94%)
USD |
NASDAQ |
Mar 26, 15:03
Zevra Therapeutics Free Cash Flow : -2.433M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Stereotaxis, Inc. | -13.78M |
| Ironwood Pharmaceuticals, Inc. | 127.01M |
| Verastem, Inc. | -147.13M |
| ADMA Biologics, Inc. | 27.50M |
| Myomo, Inc. | -17.84M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 5.516M |
| Cash from Investing (Quarterly) | 0.227M |
| Cash from Financing (Quarterly) | 2.546M |
| Free Cash Flow Per Share (Quarterly) | 0.0923 |
| Free Cash Flow to Equity (Quarterly) | 5.058M |
| Free Cash Flow to Firm (Quarterly) | 7.418M |
| Free Cash Flow Yield | -0.46% |